ArticleMedicina (Kaunas, Lithuania)2025
Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations.
Abstract readMulticenter Study
In one paragraph
Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Association between prognostic nutritional index and prognosis in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors: a meta-analysis.Frontiers in nutrition · 2026Pooled it
- Platelet-to-lymphocyte ratio for prognostication in immune checkpoint inhibitor-treated cancer patients: a meta-analysis of 13027 patients highlighting nivolumab-responsive renal cell carcinoma.Frontiers in immunology · 2026Pooled it
- An integrated host vulnerability score is associated with survival in advanced NSCLC treated with nivolumab: a PET/CT-based real-world study.BMC pulmonary medicine · 2026Article
- Predicting Postoperative Complications in Lung Cancer Spinal Metastases: A Nomogram Based on Nutritional, Low Psoas Muscle Index, and Functional Status.Current oncology (Toronto, Ont.) · 2026Article
- Predictive value of nutritional biomarkers for immune checkpoint inhibitor efficacy in patients with non-small cell lung cancer.Frontiers in nutrition · 2026Article
- Predictive value of the systemic immune-inflammation index and geriatric nutritional risk index on the efficacy of immunotherapy and survival prognosis in advanced non-small cell lung cancer: a retrospective study.American journal of cancer research · 2026Article
- A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.Frontiers in immunology · 2026Article
- Prognostic value of the Geriatric Nutritional Risk Index in sepsis-associated acute kidney injury: a retrospective cohort study.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Ozkan AlanDivision of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul 34098, Türkiye.ORCID 0000-0002-6635-2012
Tugba Akın TelliDivision of Medical Oncology, Department of Internal Medicine, Demiroglu Bilim University, Istanbul 34394, Türkiye.
Sinem AkbasDivision of Medical Oncology, Department of Internal Medicine, Koc University School of Medicine, Istanbul 34450, Türkiye.
Selver IsikDivision of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul 34854, Türkiye.ORCID 0000-0002-2726-1740
Eyyüb ÇavdarDivision of Medical Oncology, Department of Internal Medicine, Tekirdağ Namık Kemal University, Tekirdag 59030, Türkiye.ORCID 0000-0001-5885-3047
Kubilay KaraboyunDivision of Medical Oncology, Department of Internal Medicine, Tekirdağ Namık Kemal University, Tekirdag 59030, Türkiye.
Aysegül Merc CetinkayaDivision of Medical Oncology, Department of Internal Medicine, Akdeniz University, Antalya 07058, Türkiye.
Ferhat EkinciDivision of Medical Oncology, Department of Internal Medicine, Celal Bayar University, Manisa 45300, Türkiye.ORCID 0000-0002-9317-942X
Atike Pınar ErdoğanDivision of Medical Oncology, Department of Internal Medicine, Celal Bayar University, Manisa 45300, Türkiye.ORCID 0000-0003-4859-7574
Mahmut BüyükşimsekDivision of Medical Oncology, Department of Internal Medicine, Adana City Hospital, Adana 01230, Türkiye.ORCID 0000-0001-6356-9059
Muhammed Muhittin ErDivision of Medical Oncology, Department of Internal Medicine, Necmettin Erbakan University School of Medicine, Konya 42080, Türkiye.ORCID 0000-0002-0583-0295
Melek Karakurt EryilmazDivision of Medical Oncology, Department of Internal Medicine, Necmettin Erbakan University School of Medicine, Konya 42080, Türkiye.
Taliha Güçlü KantarDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Pamukkale University, Denizli 20160, Türkiye.
Gamze Gököz DoğuDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Pamukkale University, Denizli 20160, Türkiye.
Teoman SakalarDivision of Medical Oncology, Department of Internal Medicine, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaras 46050, Türkiye.
Ertuğrul BayramDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.ORCID 0000-0001-8713-7613
Ali InalDivision of Medical Oncology, Department of Internal Medicine, Mersin City Hospital, Mersin 33330, Türkiye.
Fatma Akdağ KahvecioğluDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Sakarya University, Sakarya 54290, Türkiye.
İlhan HacibekiroğluDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Sakarya University, Sakarya 54290, Türkiye.
Fatih SelçukbiricikDivision of Medical Oncology, Department of Internal Medicine, Koc University School of Medicine, Istanbul 34450, Türkiye.
Ali Murat TatliDivision of Medical Oncology, Memorial Antalya Hospital, Antalya 07025, Türkiye.
Perran Fulden YumukDivision of Medical Oncology, Department of Internal Medicine, Koc University School of Medicine, Istanbul 34450, Türkiye.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, Non-Small-Cell LungImmune Checkpoint InhibitorsLung NeoplasmsAgedAged, 80 and overFemaleHumansInflammationKaplan-Meier EstimateMaleMiddle AgedNutritional StatusNutrition AssessmentPrognosisProportional Hazards ModelsRetrospective StudiesImmune Checkpoint Inhibitorsgeriatric nutritional risk index (GNRI)immune checkpoint inhibitorsinflammation-based indicesnivolumabnon-small-cell lung cancer (NSCLC)prognostic nutritional index (PNI)
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.